Cardea Bio (part of Paragraf®)

📍 San Diego, United States🗓 Founded 2019👥 11 employees💰 Last funded 2020
Semiconductor Manufacturing🌐 cardeabio.com
Website LinkedIn
Cardea Bio is the world’s only mass producer of biocompatible semiconductors, the BPU™ (Biosignal Processing Unit). The BPU is the first and only semiconductor capable of translating real-time streams of multiomics signals into digital information. Through the BPU™ platform, Cardea's long-term vision is to democratize access to the biosignals and insights behind the most advanced technology on our planet: Nature and biology. The Internet of Biology is that way becoming possible. Cardea is headquartered in San Diego and has additional activity in Los Angeles. Cardea is a 100% American developed and built biocompatible semiconductor technology for applications across a variety of sectors including human health, agriculture, molecular diagnostics, biotechnology, environmental monitoring, and animal health. In May 2023, Cardea Bio became part of Paragraf, who has revolutionized graphene electronic device manufacturing with its pioneering scalable approach, making it the world's first company to achieve this feat. The acquisition of Cardea Bio and creation of Paragraf USA will enable Paragraf to offer a new generation of biosensing devices that will deliver the features and result sensitivity of existing lab-based instruments, with the rapid response and simple ease of use required to enable handheld, real-time, in the field use.
2
Total investors
2
Early stage
0
Mid stage
0
Late stage
2019
Founded

Investors

2 investors
All
Early stage
Mid stage
Late stage
Investor geography1 country
United States
2
Frequently asked questions
Who invested in Cardea Bio (part of Paragraf®)?
Cardea Bio (part of Paragraf®) has 2 investors on record on gritt.io, including 2 early-stage backers.
When did Cardea Bio (part of Paragraf®) last raise funding?
The most recent investment in Cardea Bio (part of Paragraf®) recorded on gritt.io was in 2020.
When was Cardea Bio (part of Paragraf®) founded?
Cardea Bio (part of Paragraf®) was founded in 2019.
What industry is Cardea Bio (part of Paragraf®) in?
Cardea Bio (part of Paragraf®) operates in Semiconductor Manufacturing. Find similar Semiconductor Manufacturing investors on gritt.io.
Where is Cardea Bio (part of Paragraf®) based?
Cardea Bio (part of Paragraf®) is headquartered in San Diego, United States.